Kemvera, formerly known as New Iridium, announced progress in commercializing biochemicals. The Denver-based company has completed its process design for a 50,000-ton-per-year plant. This is a key milestone toward large-scale production.
To support this, Kemvera finalized the design for a 500-ton pre-commercial reactor. It also commissioned a 20-ton pilot reactor, demonstrating continuous operation. These steps move the company from research into real-world manufacturing. Kemvera uses domestic feedstocks like corn ethanol to make affordable, drop-in chemicals.
The company’s rebranding reflects its goal to develop bio-based solutions that help American farmers and strengthen U.S. manufacturing. Its proprietary platform converts domestically sourced feedstocks and CO₂ into sustainable chemicals. These alternatives to petroleum products support a circular economy.
The U.S. green chemicals market is expected to reach USD 7.46 billion by 2033. Kemvera works with ethanol producers and farmers to build a resilient, local supply chain. This connects Midwest farms to industrial users.
CEO Dr. Chern-Hooi Lim said, “These milestones bring us closer to delivering affordable chemicals from American-grown feedstocks. Rebranding to Kemvera shows our focus on growth and innovation.”
Looking ahead, Kemvera plans to use its products, like bio-acetic acid and bio-ethyl acetate, in footwear, disinfectants, and other consumer goods. The company is raising Series A funding and seeking partners to expand its reach. Its goal is to boost U.S. leadership in sustainable chemicals while supporting rural economies.
The post Kemvera strengthens U.S. biochemicals with new plant milestones appeared first on World Bio Market Insights.
- Source: https://worldbiomarketinsights.com/kemvera-strengthens-u-s-biochemicals-with-new-plant-milestones/
